Minority patients were more likely to undergo the four life-sustaining procedures – gastrostomy (feeding tube insertion), tracheostomy, mechanical ventilation and hermicraniectomy (to relieve pressure on the brain) – after stroke than white patients, according to a research letter published online by JAMA Neurology. But the odds of undergoing intravenous thrombolysis and carotid revascularization – those procedures with curative intent – were lower for minority patients, according to the results. The authors note clinical factors, such as stroke severity, stroke location and time to presentation, not captured in the data could partially explain their results. Another stroke-related study published in JAMA Internal Medicine found that acute stroke treatment at a primary stroke center is associated with a seven-day and 30-day survival benefit compared to a non-certified center. The study authors suggest that admission to a PSC was associated with a 1.8% lower seven-day and 30-day death rate, although traveling at least 90 minutes to a PSC appears to offset any benefit of care there. 

Related News Articles

Headline
The AHA commented Sept. 15 on the Centers for Medicare & Medicaid Services calendar year 2026 outpatient prospective payment system and ambulatory surgical…
Headline
The AHA Sept. 15 expressed support for the Ensuring Access to Essential Providers Act, legislation that would require Medicare Advantage plans to cover…
Headline
The AHA Sept. 15 urged Aetna to rescind its recently announced “level of severity inpatient payment” policy, saying that it “could erode the transparency…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced that states can now apply for funding from the Rural Health Transformation Program created…
Headline
The AHA detailed its key health care priorities for the remainder of the year in comments to House and Senate majority and minority leaders Sept. 15. The AHA…
Chairperson's File
Public
With all of the challenges facing health care — a shrinking workforce population, reduced funding, new technologies and pharmaceuticals — it's no longer an…